HHS Secretary Spotlights Health Savings in Kennett Square Visit

106

TL/DR –

U.S. Secretary of Health and Human Services Xavier Becerra visited LCH Health and Community Services in Kennett Square during National Nurses Week to discuss the impact of the 2022 Inflation Reduction Act on healthcare affordability. The Act provides provisions for lowering healthcare costs, allowing Medicare to negotiate directly with pharmaceutical companies, and eliminating catastrophic cost-sharing. The Act has notably reduced prescription drug costs in Pennsylvania with a $35 cap on Medicare-covered insulin products and increased the number of Medicare enrollees receiving free vaccines.


Kennett Square Visit Highlights Benefits of Healthcare Legislation

During National Nurses Week, U.S. Secretary of Health and Human Services Xavier Becerra visited LCH Health and Community Services in Kennett Square, PA. Alongside Representative Chrissy Houlahan (D-PA), Becerra discussed how the 2022 Inflation Reduction Act is improving healthcare affordability and accessibility.

Becerra emphasized key provisions in the act that lower healthcare costs, notably the ability of Medicare to negotiate directly with pharmaceutical companies. “We are creating a healthcare system that’s fairer for future generations with Medicare’s new negotiating power and removed catastrophic cost-sharing,” stated Becerra.

Houlahan hailed Becerra’s visit as evidence of the administration’s dedication to affordable healthcare. “The Inflation Reduction Act reduces prescription drug expenses and out-of-pocket costs for Medicare enrollees, saving billions for American taxpayers and marking progress toward a healthier nation,” she noted.

Ronan W. Gannon, CEO of LCH Health and Community Services, applauded the administration’s fight against high healthcare costs. He indicated that over half of LCH’s patients are uninsured, and the center employs sliding fee discounts to ensure healthcare accessibility, echoing a nationwide trend at health centers.

The Inflation Reduction Act has lowered prescription drug costs significantly for Pennsylvanians, with a $35 cap on Medicare-covered insulin and considerable out-of-pocket savings to come. Medicare enrollment data shows an increase in recipients receiving free vaccines, underscoring the act’s positive effect on public health.

The act paves the way for Medicare’s first direct negotiation with drug manufacturers, offering lasting benefits for beneficiaries. Becerra’s visit to Kennett Square further emphasizes the administration’s commitment to affordable, accessible healthcare.

Stay up-to-date with the latest local happenings by following MyChesCo on Google News and Microsoft Start.


Read More US Economic News